Related Experiment Video
Updated: Mar 18, 2026

03:52
The Creation of a Rat Model for Osteosarcopenia via Ovariectomy
Published on: February 21, 2025
1.4K
Sarcopenia in critically ill patients.
Muhammet C Kizilarslanoglu1, Mehmet E Kuyumcu2, Yusuf Yesil2
1Division of Geriatrics, Department of Internal Medicine, Hacettepe University School of Medicine, 06100, Ankara, Turkey. drcemalk@yahoo.com.tr.
Journal of Anesthesia
|July 5, 2016
Summary
Sarcopenia, a loss of muscle mass and strength, affects aging individuals and can worsen in intensive care units (ICUs). This study examines sarcopenia and ICU-acquired weakness (ICU-AW) in critical care patients.
Area of Science:
- Gerontology
- Critical Care Medicine
- Muscle Physiology
Background:
- Sarcopenia is the progressive loss of skeletal muscle mass, strength, and function, primarily linked to aging.
- Its prevalence increases with age, affecting 5-13% of individuals in their sixth and seventh decades.
- Limited data exist on sarcopenia prevalence and outcomes specifically within intensive care units (ICUs).
Purpose of the Study:
- To investigate the significance of sarcopenia in ICU patients.
- To specifically examine the role and impact of ICU-acquired weakness (ICU-AW) in this population.
- To review existing literature on sarcopenia and ICU-AW in critical care settings.
Main Methods:
- Literature review of related articles.
- Search conducted in the Medline database.
- Focus on studies concerning sarcopenia and ICU-AW in intensive care unit patients.
Main Results:
- Sarcopenia prevalence increases with aging.
- ICU-acquired weakness (ICU-AW) is frequently reported in intensive care units.
- Data on sarcopenia specifically in ICUs are limited, highlighting a knowledge gap.
Conclusions:
- Sarcopenia is a significant concern in aging populations.
- ICU-AW represents a critical condition in intensive care settings.
- Further research is needed to understand sarcopenia's full impact within ICUs.
Related Concept Videos
Overview of Protein Metabolism
4.5K
Proteins are broken down into amino acids during digestion. Unlike fats and carbohydrates, which are stored for later use, proteins are not. Instead, amino acids are either used to produce ATP through oxidation or contribute to the creation of new proteins for the growth and repair of the body. Any surplus amino acids from the diet are converted into glucose or triglycerides rather than excreted.
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
4.5K
Acute Respiratory Failure-IV
687
Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
687
Bone Disorders
6.3K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
6.3K
Acute Respiratory Failure-V
619
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
619
Acute Respiratory Failure-III
1.1K
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
1.1K

